chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had a syncopal episode; only symptoms were severe muscle aches and a headache; only symptoms were severe muscle aches and a headache; The entire family had their Pfizer vaccinations in Mar, and all three are positive; The entire family had their Pfizer vaccinations in Mar, and all three are positive.; This is a spontaneous report from the contactable physician. A 68-year-old male patient received both doses (dose 1 and dose 2) of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date were unknown), via an unspecified route of administration, both doses on an unspecified date, as single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. In the last few days, Reporter had four new COVID patients after weeks of none. Three of the four were fully vaccinated, all with the Pfizer vaccine. Patient had a syncopal episode. Patient had only symptoms were severe muscle aches and a headache. The entire family had their Pfizer vaccinations in Mar, and all three are positive on an unknown date in 2021. Patient also appears to have spread it to his wife and adult daughter who are also all fully vaccinated. They had the same symptoms. The patient underwent lab tests and procedure which included SARS-CoV-2 test and was positive on an unknown date in 2021. Outcome of the events was unknown.   Information about batch/lot number has been requested; Sender's Comments: Based on temporal association and profile of the product, a contribution from the suspect drug bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), to the reported events cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Tinnitus - mild onset  becoming  progressively more  severe.  Initial  doctor  visit  03/11/2022.  Referred  to  ear, nose,  throat  doctor  03/14/2022.  Ears  and hearing appeared  normal . Diagnosis Tinnitus.  No  treatment  recommended .  Ear  ringing  continues  daily
This is a spontaneous report from a contactable Nurse. A 74-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 14Jan2021 04:45 at a single dose for COVID-19 immunization. The patient's medical history included heart attack, a history of diabetes and hypertension. Concomitant medications were not reported. On 18Jan2021, the patient experienced chills and temperature 100.1. The outcome of the event was recovering.  Information on the Lot/Batch number has been requested.
Mother states 1-1 1/2 hrs after immunizations child had rash on face, hands, arms & abdomen.
Mother noted large area of inflammation at site of vax 24 hours after they were given. Pt had a 6 x 6.5 cm area of redness, warmth, tenderness and induration. She was started on Ilosone and Motrin.
fatigue headache fever chills diarrhea vomiting body aches left lymph node is swollen still after three days
electrical shocks and legs are weak and painful - 3weeks after the 2nd dose. I started like electrical shocks under my feet. Went to doctor in June2021, Unknown diagnosis and pain meds didn't work. The pain came my left leg and I am currently taking the arthritis pain medication. Doctor may refer me to neurologist  11Oct2021 next doctor's appt
Chills and take Tylenol which makes it followed by sweating, headache, achy arm where shots administered, dizziness, upset stomach, achy muscles and joints.
Patient developed upper respiratory symptoms, cough, and fussiness one day following his 2 month immunizations. 7 days following vaccination he developed a fever to 102.7, lethargy and poor formula intake. He developed significant wheezing. Cough and wheezing lasted for about 1 month following onset. No sick contacts. Fever resolved spontaneously in 72 hours. Multiple doctor visits required for follow up in the acute setting.
Information has been received from a medical assistant concerning a 36 year old female patient with BACTRIM and BIAXIN allergy and no known medical history who on 10-FEB2009 was vaccinated intramuscularly into the right arm with the first 0.5ml dose of PNEUMOVAX 23 (Lot #662599/1076X). Concomitant therapy included hormonal contraceptives (unspecified). On 11-FEB-2009 the patient experienced swelling, warmth, decreased mobility, and pain in her right arm after vaccination. The patient was unable to tolerate anything touching her arm. The patient was started on CIPRO on 10-FEB-2009. The patient sought medical attention by office visit. At the time of reporting the patient had not recovered. In follow-up, the medical assistant reported that the patient was a 36 year old female patient, weighing 137 pounds and 60 inches in height, who was vaccinated in the right arm with the first dose of PNEUMOVAX 23. At the time of the vaccination, the patient had recurrent sinusitis. The medical assistant reported that on 11-FEB-2009, the patient experienced red swelling and pain. The patient recovered on 20-FEB-2009. Additional information is not expected.
Heart attack; This is a spontaneous report from a contactable consumer (patient). A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 24Mar2021 (at the age of 37-years-old) at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. No COVID prior vaccination. The patient experienced heart attack in 2021. The adverse event resulted in emergency room/department or urgent care, hospitalization in 2021, life-threatening illness (immediate risk of death from the event), disability or permanent damage. No COVID tested post vaccination. The outcome of the event was unknown.   Information on lot/batch number has been requested.
Pt called day after receiving both vaccines and reported pain, swelling and heat at Pneumovax injection site within 1hr of injection. Recommended she contact her MD to follow-up for treatment.
Pt recv vax on 5/4/99; on 5/5/99 pt exp local erythema & swelling at  and below vax site x 72 hr
BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 09/27/2021. PATIENT FULLY VACCINATED ON 02/24/2021. PATIENT RECEIVED MONOCLONAL ANTIBODY ON 09/28/2021.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient medical history and concurrent conditions were not reported. On 22-JAN-2016, the patient was vaccinated with incorrect stored oral, ROTATEQ (dose, lot number and expiry date were not reported). Concomitant therapy was not reported. It was reported that, temperature was 34F for 18 hours. There was no previous temperature excursion. No adverse effect was reported. This is one of several reports from the same reporter. Additional information has been requested.
next day vomited, pale, dazed expression;7OCT on face-lasted 3 to 5min;OK p/that episode;about 6PM-8PM no fever, no irritability, no redness or swelling site of inj;
Headaches and Migraines and vomiting,  Maxalt  10 mg Tylenol
Information has been received from a physician concerning a 19 year old female who on 14-NOV-2007 and 16-JAN-2007 was vaccinated intramuscularly with a 0.5 mL dose of HPV. On 16-JAN-2007, concomitant therapy included a second dose of varicella. Subsequently, on an unspecified date, the patient developed a generalized body rash (20-30 lesions) which were macular papules/erythema and were mainly on the upper extremities and some on the abdomen. There were none on the hands or feet or in the mouth. The patient did not have a temperature or lymph swelling. The papules/erythema were non-painful and not itchy. The physician stated that it did not present like chicken-pox. Routine blood work was performed (results not provided). At the time of this report, the outcome was unknown. No product quality complaint was involved. Additional information has been requested.
Suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The patient got shingles as side effect to the shingles shot. This case was considered to be a suspected vaccination failure case, as the details regarding being full vaccination schedule, laboratory confirmation for shingles and exact time to onset were unknown.
She had DTaP, IPV. At site of DTaP, she got a significant bruise per mom. It was tender when shot given, bled after.
~ 20 hours after injection, patient felt pain and itchiness at site of injection. Upon inspection site at 4pm 29 hours, after injection is slightly red, swollen with induration ~ 60mm. Varicella injection site/ 2nd dose. Tx: ice/ Tylenol and Benadryl ?
Following day, Severe headache, no energy, very achy. Since then have had mild to severe headaches on and off.  This is the 8th day since last shot,  had a headache all night, then turned bad around 1pm, now its 5pm and headache is gone. The headaches seem to come on slowly, and then leave very fast.
neck rashes; severe runny nose; uncontrollable sneezing; brain fog; joint pain; rashes; This is spontaneous report from a consumer. A 62-year-old female patient received First dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 20APR2021 as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that the patient got her first dose of the Pfizer Covid 19 vaccine last April 20, 2021 and was able to experience some side effects. She experienced brain fog, joint pain that was on and off and did not take any pain reliever, rashes and she took Benadryl twice on Thursday and Friday night, neck rashes (which happened today), severe runny nose for 2 days on Wednesday and Thursday morning and uncontrollable sneezing. She reports concerns and asks, until when will she experience these side effects and if she could take the second dose of the vaccine. On an unspecified date in Apr2021, the patient experienced brain fog, joint pain, rashes, severe runny nose and uncontrollable sneezing and neck rashes on 27Apr2021. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report was received from a health professional concerning a female patient of unknown age. The patient's medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated with MMR II (dose, route, frequency and lot no. unspecified). On an unspecified date, the patient had a serological testing for measles, mumps and rubella, and the titers came back negative for protection against rubella. It was also stated that the patient was going to see the physician on an unspecified date. The outcome of negative for protection against rubella was unknown. Additional information has been requested.
Pt. states that after receiving the 1st dose of Phizer 09/08/2021, started experiencing symptoms 09/20/2021 of bilateral rash on both arms, warm to the touch, and swollen. Primary visit 09/21/2021, treating with Antibiotic and observation. Still continuing to experience symptoms.
Morning of 11/22/2021, I woke up and noticed the ringing in my ears was very loud. This occurred after the fever had broken overnight. The tinnitus continued to be present at a louder level than I had remembered at any time prior. When it didn't change over the next few weeks, I contacted my primary doctor who suggested I might want to do some testing. From there I made an appointment with an audiologist. I saw a Dr. who confirmed my hearing was within normal range.  She suggested recommendations for coping with the tinnitus and suggested follow up should any change in hearing or tinnitus occur. She had no obvious reason for the occurrence of the tinnitus other than the possible association with vaccination based on my reported history.
A consumer report has been received. The report concerns a 7 year old Female consumer, who had been receiving FLUMIST. FLUMIST started on an unknown date. The patient experienced stomach ache, appetite decrease, red eyes, fatigue, headache, and looking tired. The outcome of the event of stomach ache, appetite decrease, red eyes, fatigue, headache and looking tired is unknown. The report was considered to be non-serious by the reporter.
Client given IPV injection and Pediarix injection which also includes IPV. CDC Immunization Hotline called Public Health advisor indicted. "No risk with additional IPV." No adverse effects
Syncopal episode with prolonged (approx 45 minute). Sleepy state afterwards. c/o headache. arrousable but then would close eyes and not interact, pale, diaphoretic positive postural vital sign changes.
Got the shingrix the 7th. Noted a papular erythematous rash on his upper inner thighs on the 12th. Then it spread to his lower back and buttocks on the 13th, On the 14th onto his inner knee and calf. The rash was not painful or itchy. Seen 2 days ago - the rash was still present but had not progressed. No treatment given. He will contact me once it has totally resolved.
Headache, Fever, Diarrhea, NauseaVomiting, shivering, site soreness, tiredness Narrative:
190 patients (9 different lot numbers) received a vaccine past the beyond used by date; No Adverse Event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No Adverse Event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date).    This case pertains to the 167th patient of the total 190 patients. It was unknown if patient received any other vaccines in the 4 weeks prior to the COVID-19 vaccine administration.  No concomitant medication was reported. No treatment medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-704335 (Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704335:Master case
patient reported acute onset of left sided weakness with associated left visual field deficit with left sided lateral hemianopsia.
On 7/23 and 24 -  ran a high fever of 101 to 102. 25th got 4 pox.
Pt began within an hour with a high pitch inconsolable cry that lasted 6 hours. The patient developed fever that lasted 6 days. Seen in ER and thought to have viral illness.
Systemic: BACK ACHE, CLOT IN LUNG-Severe, Systemic: Vomiting-Severe, Additional Details: PER PT: PT WENT TO URGENT CARE 2 DAYS AFTER ADMINISTRATION OF VACCINE. PT EXPERIENCED BACK ACHES AND STARTED COUGHING UP BLOOD/ AT URGENT CARE PT GOT A CT SCAN AND CLOT WAS SEEN IN LUNGS. PT WAS PRESCRIBED ELIQUIS AND IS WAITING FOLLOWUP BY HEMATOLOGIST
Immune was placed two days ago , site area appears red, swollen, warm to touch and soreness of the arm. Pt denies fever or head aches. Pt's mom was advise to put cold compreses and to give some Tylenol tx symptoms or to come back if worsening on the next few days.
Onset of menses immediately following vaccine (two weeks early when cycle was previously timely between the 18th and 20th), Extreme muscle and joint pain, muscle cramping, chest pain, heart palpitations/ irregular heartbeat,  brain fog, inability to focus, dizziness and extreme fatigue. My period has come twice in October after receiving the second dose on October 4th. The chest pain/heart palpitations, muscle pain, joint pain, extreme fatigue and brain fog have persisted. I received an irregular EKG on November 2nd. No prior irregular ekg?s.
Aunt reported fever of 101, cheeks red, legs sore and would not stand on legs, fussy.
I RECEIVED MY FLU & PNEUMONIA SHOTS FROM MY DR.S NURSE AROUND 10:30AM. 11/22/06 AROUND 8PM THAT EVENING I HAD SEVERE PAIN IN RIGHT ARM WHERE I HAD THE PHEUMONIA SHOT. IT KEPT GETTING WORSE. I HAD PAIN ON THE SIDE OF MY CHEST AND BREAST AS WELL. I PAGED MY DOCTOR,HE SAID HE HADN'T HEARD OF SUCH A REACTION BEFORE, AND TO KEEP ALTERNATING A HOT COMPRASS & COLD ON MY ARM, AND TAKE SOME ALEVE. ON 11/23/06 MY ARM WAS STILL IN PAIN, I TOOK IBUPROFEN, PUT HEAT & COLD ON IT ALL DAY. IN THE AFTERNOON I STARTED FEELING EXHAUSTED, A LITTLE SICK TO MY STOMACH, AND WAS STILL IN PAIN. I TOOK A NAP FOR A FEW HOURS, ATE A LITTLE DINNER, & TOOK MORE IBUPROFEN & BENADRYL. MY ARM WAS STARTING TO GET RED FROM WHERE THE SHOT WAS ADMINISTERED. AT NIGHT I EXPERIENCED CHILLS, MUSCLE CRAMPS, A FEVER OF 102 DEGREES, & MY ARM STILL HURT. ON  11/24/06 FEVER BROKE, I FELT A LITTLE EXHAUSTED BUT BETTER. MY ARM STILL IN PAIN, DEVELOPED A LARGE (BIGGER THAN AN APPLE)RED WELT. 11/25/06 THE WELT ON MY ARM GREW LARGER & TRAVELED MORE AROUNG MY ARM. 11/26/06 THE WELT ON MY ARM WRAPPED AROUND & UNDER NEAR MY ELBOW BUT WASN'T HURTING AS MUCH. I FELT SO MUCH BETTER THAN I DID DAYS BEFORE. 11/27/06 THE WELT HAS FADED FROM RED TO PINK AND ONLY FEELS LIKE MUSCLE SORENESS. 11/28/06 MY ARM JUST A LITTLE SORE, LITTLE PINK ALMOST COMPLETLEY FINE.
Pt had low grade fever & fussiness within 12 hrs /p vaccination, slept well that evenig.  Following moring infant was fine; taken to babysitter and was placed in crib for nap.  Infant was found dead ar 1:00 pm.  Autospy report list SIDS
hand swelling , difficult to make fist and bend fingers occasional wrist pain still swollen since shot 4/30/21
Sharp headache, nausea, upset stomach, dizziness, light-headedness, intense fatigue, chills?2 days so far
COVID-19; REVACCINATION WITH DIFFERENT COVID-19 VACCINE; This spontaneous report received from a patient via other manufacturer (Pfizer) concerned a 49-year-old female. The patient's height, and weight were not reported. The patient's past medical history included: penicillin allergy, and feminine wash allergy, and concurrent conditions included: hypothyroidism. Patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported, batch number: 207A21A expiry: unknown) dose was not reported, 1 total administered at left arm on 11-APR-2021 for covid-19 prophylaxis. Age at time of vaccination 48 years old. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26.cov2.s (Dose number in series 1). The patient received second dose of non-company suspect vaccine included: Moderna covid-19 vaccine (elasomeran) (Dose number in series 2) (form of admin, and route of admin were not reported, batch number: O12F21A, expiry: unknown) dose and frequency were not reported administered at right arm on 23-OCT-2021 for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with Moderna covid-19 vaccine (Dose number in series 2). The patient received third dose of non-company suspect vaccine included: Pfizer Biontech covid-19 vaccine (tozinameran) (Dose number in series 3) (form of admin and route of admin were not reported, batch number: GH9694, expiry: unknown) dose and frequency were not reported administered at right arm on 11-SEP-2022 for covid-19 prophylaxis which was revaccination with different covid-19 vaccine (Dose number in series 3). Concomitant medications included Zyrtec (cetirizine hydrochloride), Vitamin D3 (colecalciferol), Dayquil (dextromethorphan hydrobromide/guaifenesin/paracetamol/pseudoephedrine hydrochloride), and levothyroxine. On an unspecified date, the patient experienced covid-19 (Dose number in series 3). The patient was treated with non-company suspect drug Paxlovid (form of admin and route of admin was not reported, batch number: 6c7458 and expiry date was not reported) dose and frequency were not reported for covid-19 treatment from 22-DEC-2022 to 26-DEC-2022.  On 31-DEC-2022 09:00, the patient experienced Paxlovid rebound (covid-19 rebound) 5 days after the completion of Paxlovid treatment (Dose number in series 3). The action taken with covid-19 vaccine ad26.cov2.s, elasomeran, tozinameran and paxlovid was not applicable. The patient was recovering from covid-19, and the outcome of revaccination with different covid-19 vaccine was not reported. This report was non-serious.
Total Mouth Thrush includes swollen tongue, palate, gums..adverse event happened for 2 consecutive weeks ...stuffy nose, difficult breathing
A report from a health professional via medical representative concerns a child of unknown gender. No medical history, concurrent disease, or concomitant medications reported. On an unspecified date the patient received nasal FLUMIST Quadrivalent. On an unknown subsequent date the patient was diagnosed with type 1 diabetes. The outcome of the type 1 diabetes was unknown. The reporter assessed the event as non-serious. The company physician upgraded the event to serious due to medical importance. Corrected Report on 14-Feb-2014: the event of type 1 diabetes was upgraded to serious. Case upgraded to expeditable. Notes page and reporter order corrected. Responsible physician was deleted.
pt recv vax & devel gen hives & itching, lip swelling & numbness;treated w/DPh & steroid dose pack x 4 days;